Mabtas T 100 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Mabtas T 100 mg Injection

Mabtas T 100 mg Injection

Mabtas T 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune conditions. It is used for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and certain inflammatory blood-vessel disorders. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Rituximab works by targeting the CD20 protein on B-cells and helping the immune system remove abnormal or overactive B-cells. It may be used alone or together with other medicines according to the patient’s condition and prescribed treatment protocol. Patients require monitoring during treatment because infusion reactions, infections, and changes in blood-cell counts can occur. The treatment dose and schedule are determined by the specialist based on the disease, clinical response, and individual patient factors.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 10 mg/mL
Dosage Form Solution for Injection
Route of Administration Intravenous Infusion
Pack Size 10 mL, 1 Vial

Product Also Known As

Mabtas T 100mg Injection, Mabtas T 100 mg Injection, Mabtas T 100mg Vial, Rituximab 100mg Injection, Rituximab 100 mg Injection, Rituximab 100mg Infusion, Rituximab 10mg/mL Injection